Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2003 Cultural Differences at the End of Life Diane Rapaport, MD Physicians must be mindful of how cultural attitudes regarding death and end-of-life care that will impact patients' decisions regarding a loved one. Virtual Mentor. 2003;5(6):201-204. doi: 10.1001/virtualmentor.2003.5.6.ccas1-0306. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411. Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Current page 10
Case and Commentary Jun 2003 Cultural Differences at the End of Life Diane Rapaport, MD Physicians must be mindful of how cultural attitudes regarding death and end-of-life care that will impact patients' decisions regarding a loved one. Virtual Mentor. 2003;5(6):201-204. doi: 10.1001/virtualmentor.2003.5.6.ccas1-0306.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411.